title: Performance of the marginal structural models under various scenarios of incomplete marker's values: a simulation study.
abstract: Marginal structural models (MSMs) have been proposed for estimating a treatment's effect, in the presence of time-dependent confounding. We aimed to evaluate the performance of the Cox MSM in the presence of missing data and to explore methods to adjust for missingness. We simulated data with a continuous time-dependent confounder and a binary treatment. We explored two classes of missing data: (i) missed visits, which resemble clinical cohort studies; (ii) missing confounder's values, which correspond to interval cohort studies. Missing data were generated under various mechanisms. In the first class, the source of the bias was the extreme treatment weights. Truncation or normalization improved estimation. Therefore, particular attention must be paid to the distribution of weights, and truncation or normalization should be applied if extreme weights are noticed. In the second case, bias was due to the misspecification of the treatment model. Last observation carried forward (LOCF), multiple imputation (MI), and inverse probability of missingness weighting (IPMW) were used to correct for the missingness. We found that alternatives, especially the IPMW method, perform better than the classic LOCF method. Nevertheless, in situations with high marker's variance and rarely recorded measurements none of the examined method adequately corrected the bias.
authors.affiliation: Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Mikras Asias 75, 11527, Athens, Greece.
authors.forename: Georgia
authors.initials: G
authors.lastname: Vourli
authors.forename: Giota
authors.initials: G
authors.lastname: Touloumi
mesh_terms: D000410:Alanine Transaminase / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D001699:Biometry / Q000379:methods*; D006514:Hepatitis B Surface Antigens / Q000378:metabolism; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D015233:Models, Statistical; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D006514:Hepatitis B Surface Antigens; D000410:Alanine Transaminase
keywords: Marginal structural models; Missing data; Survival